EcoDrugPlus

Nicastrin

Ensembl ID : ENSOMYG00000045004
Gene Symbol: NCSTN
1 Cross references
197 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSOMYG00000045093
Gene Symbol: NAMPT
1 Cross references
220 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSOMYG00000042504
Gene Symbol: NAMPT
1 Cross references
217 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSOMYG00000020821
Gene Symbol: NAMPT
1 Cross references
154 Possible Orthologues:

Notch 1

Ensembl ID : ENSOMYG00000039949
Gene Symbol: NOTCH1
2 Cross references
196 Possible Orthologues:

Notch Receptor 3

Ensembl ID : ENSOMYG00000042475
Gene Symbol: NOTCH3
1 Cross references
196 Possible Orthologues:

Notch Receptor 3

Ensembl ID : ENSOMYG00000041258
Gene Symbol: NOTCH3
1 Cross references
196 Possible Orthologues:

Nuclear Receptor Subfamily 1, Group H, Member 3

Ensembl ID : ENSOMYG00000025876
Gene Symbol: NR1H3
1 Cross references
385 Possible Orthologues:

Nuclear Receptor Subfamily 1, Group H, Member 3

Ensembl ID : ENSOMYG00000013850
Gene Symbol: NR1H3
2 Cross references
384 Possible Orthologues:

Nuclear Receptor Subfamily 1, Group H, Member 4

Ensembl ID : ENSOMYG00000045591
Gene Symbol: NR1H4
1 Cross references
381 Possible Orthologues:

Nuclear Receptor Subfamily 1, Group H, Member 4

Ensembl ID : ENSOMYG00000022907
Gene Symbol: NR1H4
1 Cross references
381 Possible Orthologues:

Nuclear Receptor Subfamily 3 Group C Member 1

Ensembl ID : ENSOMYG00000014588
Gene Symbol: NR3C1
1 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).